Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.

Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, Kawana M, Hagiwara N.

J Thorac Imaging. 2013 Jan;28(1):60-6. doi: 10.1097/RTI.0b013e3182761830.

PMID:
23249970
2.

Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.

Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, Amaki M, Kanzaki H, Okamura H, Kamakura S, Shimizu W, Anzai T, Kitakaze M.

Heart. 2014 Aug;100(15):1165-72. doi: 10.1136/heartjnl-2013-305187. Epub 2014 May 14.

PMID:
24829369
3.

Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.

Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.

J Med Assoc Thai. 2011 Feb;94 Suppl 1:S33-8.

PMID:
21721426
4.

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study.

Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, Lang RM, Burke MC, Garrity ER, Hogarth DK, Archer SL, Sweiss NJ, Beshai JF.

Eur J Heart Fail. 2011 Nov;13(11):1231-7. doi: 10.1093/eurjhf/hfr099. Epub 2011 Aug 2.

5.

Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.

Cain MA, Metzl MD, Patel AR, Addetia K, Spencer KT, Sweiss NJ, Beshai JF.

Am J Cardiol. 2014 May 1;113(9):1556-60. doi: 10.1016/j.amjcard.2014.01.434. Epub 2014 Feb 12.

PMID:
24731652
6.

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ.

J Am Coll Cardiol. 2005 May 17;45(10):1683-90. Epub 2005 Apr 25.

7.

Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.

Yang Y, Safka K, Graham JJ, Roifman I, Zia MI, Wright GA, Balter M, Dick AJ, Connelly KA.

J Magn Reson Imaging. 2014 Mar;39(3):609-16. doi: 10.1002/jmri.24196. Epub 2013 May 29.

PMID:
23720077
8.

QRS-based assessment of myocardial damage and adverse events associated with cardiac sarcoidosis.

Sobue Y, Harada M, Koshikawa M, Ichikawa T, Yamamoto M, Okuda K, Kato Y, Sarai M, Watanabe E, Ozaki Y.

Heart Rhythm. 2015 Dec;12(12):2499-507. doi: 10.1016/j.hrthm.2015.09.008. Epub 2015 Sep 8.

PMID:
26362576
9.

Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.

McLellan AJ, McKenzie SC, Taylor AJ.

Heart Lung Circ. 2012 Jan;21(1):30-5. doi: 10.1016/j.hlc.2011.09.005. Epub 2011 Nov 3.

PMID:
22055931
10.

CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.

Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H.

JACC Cardiovasc Imaging. 2013 Apr;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021. Epub 2013 Mar 14.

11.

Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.

Ling LH, Taylor AJ, Ellims AH, Iles LM, McLellan AJ, Lee G, Kumar S, Lee G, Teh A, Medi C, Kaye DM, Kalman JM, Kistler PM.

Heart Rhythm. 2013 Sep;10(9):1334-9. doi: 10.1016/j.hrthm.2013.06.019. Epub 2013 Jun 27.

PMID:
23811081
12.

Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias.

Hasdemir C, Yuksel A, Camli D, Kartal Y, Simsek E, Musayev O, Isayev E, Aydin M, Can LH.

Pacing Clin Electrophysiol. 2012 Apr;35(4):465-70. doi: 10.1111/j.1540-8159.2011.03324.x. Epub 2012 Feb 3.

PMID:
22303908
13.

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.

Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR.

Circ Cardiovasc Imaging. 2016 Jan;9(1):e003738. doi: 10.1161/CIRCIMAGING.115.003738.

14.

Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation.

Glaveckaite S, Valeviciene N, Palionis D, Skorniakov V, Celutkiene J, Tamosiunas A, Uzdavinys G, Laucevicius A.

J Cardiovasc Magn Reson. 2011 Jul 25;13:35. doi: 10.1186/1532-429X-13-35.

15.

Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.

Zhu Y, Park EA, Lee W, Kim HK, Chu A, Chung JW, Park JH.

Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18.

PMID:
25597022
16.

MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function.

Ichinose A, Otani H, Oikawa M, Takase K, Saito H, Shimokawa H, Takahashi S.

AJR Am J Roentgenol. 2008 Sep;191(3):862-9. doi: 10.2214/AJR.07.3089.

PMID:
18716120
17.

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG.

Kidney Int. 2006 May;69(10):1839-45.

18.

Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.

Wu KC, Weiss RG, Thiemann DR, Kitagawa K, Schmidt A, Dalal D, Lai S, Bluemke DA, Gerstenblith G, Marbán E, Tomaselli GF, Lima JA.

J Am Coll Cardiol. 2008 Jun 24;51(25):2414-21. doi: 10.1016/j.jacc.2008.03.018.

19.

Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy.

Alter P, Rupp H, Adams P, Stoll F, Figiel JH, Klose KJ, Rominger MB, Maisch B.

Eur J Heart Fail. 2011 Sep;13(9):937-44. doi: 10.1093/eurjhf/hfr082. Epub 2011 Jul 28.

20.

Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.

Kim J, Kochav JD, Gurevich S, Afroz A, Petashnick M, Volo S, Diaz B, Okin PM, Horn E, Devereux RB, Weinsaft JW.

Int J Cardiovasc Imaging. 2014 Dec;30(8):1559-67. doi: 10.1007/s10554-014-0487-8. Epub 2014 Jul 10.

Supplemental Content

Support Center